< Terug naar vorige pagina

Octrooi

Means and methods for treatment of early-onset parkinson's disease

The present invention relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular the invention has found that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
Octrooi-publicatienummer: EP3220901
Jaar aanvraag: 2020
Jaar toekenning: 2020
Jaar van publicatie: 2020
Status: Toegewezen
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven